Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Loss	Non-controlling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred stock, shares outstanding (in shares)		0
Beginning balance (in shares) at Mar. 25, 2022			190,473,595
Beginning balance at Mar. 25, 2022	$ 735,363	$ 0	$ 1,905	$ 627,792	$ 122,958	$ (18,448)	$ 1,156
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	187,494				187,357		137
Cash dividends to non-controlling interest	(42)						(42)
Employee stock purchase plan issuances (shares)			161,726
Employee stock purchase plan issuances	2,793		$ 2	2,791
Stock-based compensation, net of forfeitures and restricted stock vested (in shares)			1,118,971
Stock-based compensation, net of forfeitures and restricted stock vested	61,668		$ 11	61,657
Payments of taxes withheld on net settlement of equity awards	(18,061)			(18,061)
Foreign currency translation adjustment	(2,892)					(2,828)	(64)
Net actuarial gain (loss) on amortization of net transition obligation and prior service costs related to defined benefit plans, net of tax	492					492
Preferred stock, ending balance (in shares) at Mar. 31, 2023		0
Ending balance (in shares) at Mar. 31, 2023			191,754,292
Ending balance at Mar. 31, 2023	966,815	$ 0	$ 1,918	674,179	310,315	(20,784)	1,187
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred stock, shares outstanding (in shares)		0
Net income (loss)	152,888				152,697		191
Employee stock purchase plan issuances (shares)			144,226
Employee stock purchase plan issuances	3,635		$ 1	3,634
Stock-based compensation, net of forfeitures and restricted stock vested (in shares)			1,266,091
Stock-based compensation, net of forfeitures and restricted stock vested	42,432		$ 13	42,419
Payments of taxes withheld on net settlement of equity awards	(25,900)			(25,900)
Foreign currency translation adjustment	(7,720)					(7,623)	(97)
Net actuarial gain (loss) on amortization of net transition obligation and prior service costs related to defined benefit plans, net of tax	$ (434)					(434)
Preferred stock, ending balance (in shares) at Mar. 29, 2024	0	0
Ending balance (in shares) at Mar. 29, 2024	193,164,609		193,164,609
Ending balance at Mar. 29, 2024	$ 1,131,716	$ 0	$ 1,932	694,332	463,012	(28,841)	1,281
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred stock, shares outstanding (in shares)	0	0
Net income (loss)	$ (72,763)				(73,010)		247
Cash dividends to non-controlling interest	(19)						(19)
Employee stock purchase plan issuances (shares)			164,756
Employee stock purchase plan issuances	3,511		$ 2	3,509
Stock-based compensation, net of forfeitures and restricted stock vested (in shares)			974,517
Stock-based compensation, net of forfeitures and restricted stock vested	41,802		$ 9	41,793
Issuance of common stock, net of underwriting discounts (in shares)			28,750,000
Issuance of common stock, net of underwriting discounts	665,850		$ 288	665,562
Repurchases of common stock			(38,767,315)
Repurchases of common stock, value	(820,884)		$ (388)	(376,903)	(443,593)
Payments of taxes withheld on net settlement of equity awards	(16,238)			(16,238)
Foreign currency translation adjustment	(2,127)					(2,163)	36
Net actuarial gain (loss) on amortization of net transition obligation and prior service costs related to defined benefit plans, net of tax	$ 252					252
Preferred stock, ending balance (in shares) at Mar. 28, 2025	0	0
Ending balance (in shares) at Mar. 28, 2025	184,286,567		184,286,567
Ending balance at Mar. 28, 2025	$ 931,100	$ 0	$ 1,843	$ 1,012,055	$ (53,591)	$ (30,752)	$ 1,545
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred stock, shares outstanding (in shares)	0	0